Fact CheckerSign in

NCT07564193Not yet recruiting

The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV

The Coach Mpilo Study: Evaluation of a Peer-led Intervention to Promote Engagement in HIV Care for Men Living With HIV in South Africa

Source: ClinicalTrials.gov · Last updated 11 May 2026

Brief summary (registry, in English)

Developed in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide support to their peers and help them address psychosocial barriers in accessing and staying in HIV care. The peers employed by Coach Mpilo provide individualized assistance to men who are struggling with medication adherence and clinic visits, focusing on specific barriers ranging from knowledge about the benefits of HIV treatment, stigma, mental health, and social isolation. Through a randomised control trial, this project will (1) determine the impact of the Coach Mpilo intervention on retention in HIV care, viral suppression, HIV treatment adherence, mental health, HIV stigma, and economic status; (2) identify populations of men who may not benefit from the intervention and require alternative support; and (3) assess the intervention's cost-effectiveness.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
800 (estimated)
First submitted
26 Apr 2026
Start date
11 May 2026
Primary completion date
Sept 2027
Lead sponsor
University of Cape Town
Diseases
HIV
NCT number
NCT07564193

What you commit to

  • Study type: Interventional
  • Planned participants: 800
  • From 11 May 2026 to the primary completion date, Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • not meeting inclusion criteria

Who the study is looking for

  • Male (cisgender or transgender);
  • aged ≥18 years;
  • previously receiving HIV care at the study clinic;
  • missed their most recent ART (antiretroviral therapy) clinic appointment by \>28 days;
  • not planning to relocate to another region within the next 12 months;
  • able and willing to provide informed consent;
  • not currently taking ART

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Multisite study with several health care facilities
Coordinator of this site? Confirm its status
DurbanSouth AfricaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.